TherapeuticsMD Inc.
TXMD | NASDAQ
$2.10
-$0.09 (-4.11%)
At close: Sep 21, 2026, 4:00 PM ET
$2.10
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $24.31M
Enterprise Value $20.68M
Beta 0.65
Average Volume 36.01K
Shares Outstanding (Diluted) 11.64K
Shares Change YoY -99.9%
Institutional Ownership 33.96%
Exchange NASDAQ
ISIN US88338N2062
Price Performance
Price Change 1M 1.9%
Price Change 3M 5.0%
Price Change 6M -8.3%
Price Change YTD 27.3%
Price Change 1Y 94.4%
Price Change 3Y -30.2%
Price Change 5Y -94.2%
1M CAGR (ann.) 1.4%
1Y CAGR (ann.) 94.4%
5Y CAGR (ann.) -44.3%
All-Time CAGR -32.4%
Valuation
PE Ratio -94.59
Forward PE 11.06
PEG Ratio -0.10
Forward PEG -9.49
PS Ratio 7.43
Forward PS 2.60
PB Ratio 0.90
P/FCF Ratio 7.75
P/Adj. FCF Ratio 7.76
P/OCF Ratio 7.78
EV/Sales 6.32
EV/EBIT -5.00
EV/EBITDA -6.80
EV/FCF 6.59
Earnings Yield -1.1%
FCF Yield 12.9%
Adj. FCF Yield 12.9%
Financial Health
Net Cash $9.19M
Total Debt $5.56M
Cash & Short-Term Investments $9.19M
Total Assets $37.53M
Current Ratio 3.22
Quick Ratio 3.22
Debt / Equity Ratio 0.20
Debt / EBITDA -1.83
Debt / FCF 1.77
OCF / Debt 0.56
Interest Coverage -963.00
Altman Z-Score -34.04
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 89.9%
Operating Profit Margin -118.2%
EBITDA Margin -128.3%
Net Profit Margin -6.6%
FCF Margin 95.9%
Adj. FCF Margin 95.8%
SBC / Revenue 0.0%
SBC Impact (per share) -0.2%
Returns
Return on Assets -0.6%
Return on Equity -0.8%
Return on Invested Capital -11.5%
Return on Capital Employed -11.8%
Return on Tangible Assets -0.6%
Historical Growth (CAGR)
Revenue CAGR 3Y -47.8%
Revenue CAGR 5Y -47.9%
Revenue CAGR 10Y -16.6%
EPS CAGR 3Y 129.4%
EPS CAGR 5Y 70.4%
EPS CAGR 10Y 24.8%
FCF CAGR 3Y -54.0%
FCF CAGR 5Y -46.7%
FCF CAGR 10Y 29.6%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 16, 2026
EPS Estimate (next Q) -$6.12
EPS Growth Est (next Q) -46748.9%
Revenue Est (next Q) $19.77M
Revenue Growth Est (next Q) 2421.4%
Cash Flow
Operating Cash Flow $3.14M
Free Cash Flow $3.14M
Adj. Free Cash Flow $3.13M
FCF Per Share $0.27
OCF Per Share $0.27
OCF/S Ratio 95.4%
Income Statement
Revenue $3.27M
Gross Profit $2.95M
Operating Income $-3.87M
EBITDA $-3.04M
Net Income $-217K
EPS (Diluted) -$0.02
Revenue / Employee $3.27M
Profit / Employee $-217K
Employees 1
Add to Watchlist
Select watchlists to add or remove TXMD